My question is: How on earth can an IRB allow the study to continue after that? It strikes me as profoundly unethical to subject mild to moderately ill patients who will very likely recover uneventfully to such risk.
-
-
Show this threadThanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
FWIW, the stance of Russians is roughly the same. "As soon as there are abnormalities in ECG, the cocktail should be stopped immediately. Also, these drugs should only be used in ICU by trained specialists, don't buy them, let alone take them at home"
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
But Rudy said it was a great drug?
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
fitting "cure can't be worse than disease" promoted a cure that is potentially as deadly as the disease
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
This Tweet is unavailable.
-
This Tweet is unavailable.
- Show replies
-
-
-
The article mentions 1 patient. Not "patients": "nous avons mis en évidence des risques majeurs d’accident gravissime chez UNE (one) patiente, et le traitement a aussitôt été stoppé"
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
Thanks. Twitter will use this to make your timeline better. UndoUndo
-
-
-
To help you understand : the protocol that they follow in the article is to give HCQ + AZY only to people in reanimation (when it is too late). Indeed, at this stage, HCQ is ineffective...
-
Yes they’ve got to give early enough so that the drug cocktail can be given credit for the people who would’ve gotten better anyway. This is exactly why this cocktail, with no good evidence that it works, should only be used as part of a rigorously designed clinical trial.
End of conversation
New conversation -
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.
